(Q42637253)

4 November 2017

Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients (English)

1 reference

4 November 2017

1 reference

Alan Jardine

7

0 references

Winfried März

4

object named as

Winfried März

1 reference

4 November 2017

Sadollah Abedini

1

1 reference

4 November 2017

Andreas Meinitzer

2

1 reference

4 November 2017

Ingar Holme

3

1 reference

4 November 2017

Gisela Weihrauch

5

1 reference

4 November 2017

Bengt Fellstrøm

6

1 reference

4 November 2017

Hallvard Holdaas

8

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

4 November 2017

1 reference

4 November 2017

77

1 reference

4 November 2017

1

1 reference

4 November 2017

44-50

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2009.382

4 November 2017

0 references

cites work

Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Preventing cardiovascular outcome in patients with renal impairment: is there a role for lipid-lowering therapy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Arterial stiffness and renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Arterial stiffness and wave reflections in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Cerebrovascular events in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

ADMA increases arterial stiffness and decreases cerebral blood flow in humans.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Arginine, arginine analogs and nitric oxide production in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Protection of Wistar Furth Rats from Chronic Renal Disease Is Associated with Maintained Renal Nitric Oxide Synthase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Nitric oxide modulates vascular disease in the remnant kidney model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.382

7 January 2021

Identifiers

DOI

10.1038/KI.2009.382

1 reference

4 November 2017

1 reference